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Abstract
When assessing the potential benefits of HBOT in oncology patients
occasional confusion arises when extrapolating the cytokine, epigenetic
and other effects of HBOT in non-cancerous tissues (neurological and
other injuries etc.) versus those in cancerous tissues.
This confusion often results in misinterpretation of data and concern
over potential harm in HBOT oncology cases. The focus of this
presentation is to point out the data supporting these differences as we
know it to date and underscore the benefits while decreasing this
clinical confusion.
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Dr. Paul Anderson - Background
• CEO – Anderson Medical Group
• Chief medical advisor – Sanoviv’ Hospital
• Content Director CE site ‘ConsultDrA.com’
• Past Positions:
• Full Research Professor – Bastyr University
• Research Partner in NIH and other national funding sourced projects with the
CUSIOS group and University of Washington, Seattle Cancer Care Alliance and
Fred Hutchinson Research Center.
• Original site director of “US Site-1” for the CUSIOS Oncology study.
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Advanced Medical Therapies
(Seattle, Washington)
• IV Therapies
• Mild-Moderate
Hyperthermia
• Hyperbaric Oxygen
• Other specialty
therapies
• Care focus is on
cancer and
advanced chronic
illness.
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Sanoviv’ Hospital
(Rosarito, Mexico)
•
•
•
•
•
•

Inpatient facility
IV Therapies
Metronomic chemotherapy
Multi-place HBOT
Hyperthermia
Cancer vaccine and Rigvir
programs etc. etc.
• Care for patients with
Cancer and Chronic
Illnesses.
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HBOT 2016 & 2017
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Other Resources not directly referenced:
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Cancer (Methods)
Cancer (Patient outcomes)
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Key Point:
Normal tissue and wounded tissue DO NOT act like
Tumor and Tumor Environments under HBOT

HBOT Effect in one ≠ The
other!
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[1]
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Epithelial-mesenchymal Transition
(EMT)
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Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition.
The Journal of Clinical Investigation. 2009;119(6):1420-1428.
doi:10.1172/JCI39104. (this and the following 2 slides)
Type 3 EMTs occur in the context of tumor growth and cancer progression,
when cancer cells at the invasive front of the tumors convert to a

mesenchymal phenotype.
The induction of type 3 EMTs is facilitated by the genomic alterations

acquired by cancer cells and these EMTs generate cells with invasive
properties that enable them to move into the blood stream and spread

systemically to other organs.
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HBOT and EMT? [2]

i.e. “via the N-cadherin pathway (see below) under HBOT therapy (2.47
ATA in Mice) EMT was down-regulated.
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EMT Post-HBOT (less N-cad and AXL) [2]
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Of note: MET in any paper or figure is EMT
reversing.
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Hypoxia Induction Factor
HIF-1
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https://ars.els-cdn.com/content/image/1-s2.0-S2211383515000817-gr1.jpg
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HIF-1 and HBOT in NORMAL Tissue

https://openi.nlm.nih.gov/imgs/512/203/4292106/PMC4292106_IJPS-47-303-g001.png
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HIF-1 and Tumors
Hypoxia, via HIF-1a, causes translocation to the
nucleus and increase the transcription of
multiple genes associated with this aggressive
behaviour. Thus, since HBOT enhanced the pO2
in tissues temporarily, and O2 is important for
degrading HIF-1a, we expected reduction in
tumor growth. [2]
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In non-cancerous inflamed tissue HBOT does
not generally lower HIF-1 [5]
OBJECTIVES: This study investigated the role of hypoxia-inducible factor
1alpha (HIF-1alpha) in acute pancreatitis (AP) and whether HIF-1alpha is
involved in the therapeutic effects of hyperbaric oxygen (HBO) on AP.
METHODS: Thirty Wistar rats with taurocholate-induced AP were randomly
assigned to 3 groups…
RESULTS: The HBO therapy attenuated the severity of acute pancreatitis; …
The HBO therapy inhibited AP-induced up-regulation of HIF-1alpha and its
downstream effector [VEGF] and the production of [TNF]-alpha and
myeloperoxidase activity.
CONCLUSIONS: Hypoxia-inducible factor 1alpha plays a key role in the
pathogenesis of AP, and the ability to down-regulate the expression of HIF1alpha may partially explain the therapeutic effect of HBO on AP.
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HIF-1 and VEGF
HIF-1a is a key oxygen-regulator of VEGF gene expression which is important for angiogenesis
and thus tumor growth. [2]  REDUCING TUMOR HYPOXIA DECREASES VEGF.

http://journals.plos.org/ploscompbiol/article/figure/image?download&size=large&id=info:doi/10.1371/journal.pcbi.1004612.g001
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In vitro no significant vascular diameter change
and vessel density rose in 1 cell type at 2.5 BAR
(2.47 ATA) in cell culture over 24 days. [2]
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Aggravation of
Macular Degeneration

https://www.selfhacked.com/wp-content/uploads/2016/05/ImageDownloadService.jpeg
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HBOT in NORMAL TISSUE does not generally
lower VEGF [16]
Background: Hyperbaric oxygen (HBO) therapy is an effective adjunct
treatment for ischemic disorders such as chronic infection or chronic
wounds. It combines hyperoxic effects with the stimulating potential of
posttherapeutic reactive hypoxia. As its crucial effects, stimulation of
fibroblast growth, induction of collagen synthesis and the initiation of
angiogenesis are discussed. Angiogenesis is a multistage process resulting in
the growth of blood vessels. It includes degradation of extracellular matrix,
proliferation and migration of different cell populations and finally formation
of new vessel structures. This complex chain of procedures is orchestrated
by different cytokines and growth factors. Crucial mediators of angiogenesis
are basic fibroblast growth factor (bFGF) and vascular endothelial growth
factor (VEGF); their in-vivo function is still not fully understood.
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HBOT in NORMAL TISSUE does not generally
lower VEGF [16]
Methods: Forty-three patients suffering from sudden sensorineural
hearing loss or tinnitus were treated with HBO. The therapy included
10 sessions of 90 minutes each, one session a day. [* 1.55 BAR / 1.53
ATA] Serological levels of bFGF and VEGF were assessed by [ELISA] on
day 1, 2, 5 and 10 of HBO therapy and were compared to mean values
of the control group, related to the patient’s age and sex, and their
development observed over the ten days of HBO.
Conclusions: A significant effect of HBO on serum concentrations of
bFGF and VEGF was not verified in the present study. Additional
application of exogenous growth factors in conjunction with HBO was
not obviously linked by a coherent cause-and-effect chain as far as
wound healing is concerned.
(c) PS Anderson - www.ConsultDrA.com - 2018

49

In non-cancerous inflamed tissue HBOT
NORMALIZES VEGF and decreases TNFa… [5]
OBJECTIVES: This study investigated the role of hypoxia-inducible factor
1alpha (HIF-1alpha) in acute pancreatitis (AP) and whether HIF-1alpha is
involved in the therapeutic effects of hyperbaric oxygen (HBO) on AP.
METHODS: Thirty Wistar rats with taurocholate-induced AP were randomly
assigned to 3 groups…
RESULTS: The HBO therapy attenuated the severity of acute pancreatitis; …
The HBO therapy inhibited AP-induced up-regulation of HIF-1alpha and its
downstream effector [VEGF] and the production of [TNF]-alpha and
myeloperoxidase activity.
CONCLUSIONS: Hypoxia-inducible factor 1alpha plays a key role in the
pathogenesis of AP, and the ability to down-regulate the expression of HIF1alpha may partially explain the therapeutic effect of HBO on AP.
(c) PS Anderson - www.ConsultDrA.com - 2018

50

Apoptosis
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Apoptosis
• Apoptosis (programmed cell death) is one of those processes that are
only supposed to go one way.
• Once begun, there is no turning back.

• The cell begins to degrade itself through the activation of caspases,
proteolytic enzymes that cleave the structural elements of the cell,
leading to a series of morphological and biochemical changes.
• The cell digests itself from the inside, turning itself to a colloid of dead organic
molecules inside the cell membrane.
• In the end, it fragments neatly into membrane-enclosed vacuoles that are
then phagocytosed by nearby cells.
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Apoptosis Induction Factor (AIF) processing is sequentially
regulated by Ca2+ and ROS.

E. Norberg et al. / Biochemical and Biophysical Research Communications 396 (2010) 95–100
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Moen I and Stuhr I. Hyperbaric oxygen therapy and cancer—a review.
Target Oncol. 2012 Dec; 7(4): 233–242. Published online 2012 Oct 2. doi: 10.1007/s11523-012-0233-x PMCID:
PMC3510426 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510426/

• Studies of apoptosis in neoplasms treated with HBO are limited. Two in
vitro studies on mammary and oral cancer cells, respectively, showed no
change in apoptosis after HBO [18, 19].
• On the other hand, Chen et al. [20] observed activation of the proapoptotic pathway MAPK and downregulation of the anti-apoptotic ERK
pathway in hematopoetic cells after HBO.
• Additionally, a study of HBO using osteosarcoma cells also demonstrated
induction of apoptosis [21].
• In two different animal models, gliomas and mammary tumors,
respectively, our group has demonstrated induction of cell death after
HBO treatment [22–24].
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Moen I and Stuhr I. Hyperbaric oxygen therapy and cancer—a review.
Target Oncol. 2012 Dec; 7(4): 233–242. Published online 2012 Oct 2. doi: 10.1007/s11523-012-0233-x PMCID:
PMC3510426 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510426/

• Furthermore, reduced cell proliferation, together with a
significant change in histology, has also been shown after
HBO treatment in DMBA-induced mammary tumors in vivo
[22, 24].
• Granowitz et al. [18] observed the same reduction in cell
proliferation in their mammary in vitro study. In addition,
two recent studies on osteosarcoma cells [21] and
nasopharyngeal carcinoma [25] support inhibition of cell
division after HBO treatment.
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Hypoxia, Apoptosis and HBOT [6]
Hypoxic cancer cells survive via the adaptation to
the unfavorable conditions. Moreover, they are
related with tumor recurrences and interfere
with treatment success in many types of
malignancies.
Hypoxia affects angiogenesis, apoptosis and
many gene products that are involved in
glycolysis directly.
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Hypoxia, Apoptosis and HBOT [6]
The target genes regulated by hypoxia mediate
tumor progression through an epigenetic
mechanism. Hypoxia is essential for hypoxiainducible factor (HIF) -1 α stabilization and
following vascular endothelial growth factor
(VEGF) expression.
Tumor oxygenation can be increased via
hyperbaric oxygen therapy (HBOT).
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Hypoxia, Apoptosis and HBOT [6]
HBOT increases oxygen perfusion of the tumor
tissues,
changes hypoxic microenvironment,
can increase apoptosis via ROS production and
abolish antioxidant defense mechanisms of the
tumors.
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In non-cancerous brain tissue HBOT decreases
apoptosis during ischemia-reperfusion. [4]
“… These results indicate that HBO has multiple actions
on apoptotic genes even though the overall effect of
HBO was decreased HIF-1alpha expression and reduced
apoptosis after global ischemia-hypotension.”
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AXL & RTK
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http://www.mdpi.com/cancers/cancers-08-00103/article_deploy/html/images/cancers-08-00103-g002.png
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https://www.researchgate.net/profile/Bruno_Fonseca4/publication/267867892/figure/fig2/AS:392192783863815@1470
517454609/Hyperactivated-mTOR-pathway-leads-to-dysregulation-of-translational-control-and-cancer.png
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Axl RTK DECREASED BY HBOT
We also demonstrated a reduction in the expression of Axl RTK in the
HBOT tumors. Axl RTK has been correlated with poor outcome and
drug resistance in a wide range of cancer types, and has been shown to
be necessary for maintaining tumor EMT. Axl RTK has been shown to be
upregulated in human breast cancer samples, and to be associated
with a reduced patient survival.
Furthermore, Axl RTK expression remained an independent negative
prognostic factor in a multivariate analysis including basic prognostic
factors, and a hazard ratio of 3.27 were detected between cases with
high and low Axl expression. [2]
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Axl RTK DECREASED BY HBOT
In an experimental tumor model, the authors demonstrated that Axl
knockdown completely prevented the spread of highly metastatic
breast carcinoma cells from the mammary gland to lymph nodes and
several major organs and increased overall survival.
Taken together, it is likely to assume based on the findings from our
study that enhanced oxygen could be critically involved in MET
transition of developing breast tumors, and also be implicated in the
reduced metastatic potential observed after HBOT in the present
study. [2]
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N-cadherin

(c) PS Anderson - www.ConsultDrA.com - 2018

65

https://journals.prous.com/journals/dof/20073210/html/df320925/images/fig01.gif
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N-cadherin & HBOT
And although nuclear localisation of N-cadherin has
rarely been described in human solid tumors, it has
been shown to correlate with poor prognosis in
nasopharyngeal carcinoma (NPC). In this study, a high
expression of nuclear N-cadherin predicted a poorer
survival in patients with late stage disease, and
multivariate analysis showed nuclear N-cadherin to be
an independent prognostic marker for NPC patients. [2]
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N-cadherin
In the present MDA-MB-231 model, we found a significant
reduction in N-cadherin after HBOT. In most types of cancer,
high N-cadherin expression correlates with cell motility,
invation and metastasis. Furthermore, N-cadherin was
demonstrated to be localized to the nucleus in our
experimental tumor model, and aberrant N-cadherin in the
nucleus has been shown to be necessary for cell migration
during EMT. [2]

(c) PS Anderson - www.ConsultDrA.com - 2018

68

Tumor Stroma
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Tumor Stroma (depending on signaling)
Promotes Cancer Progression [17]
Maintenance of both normal epithelial tissues and their malignant
counterparts is supported by the host tissue stroma. The tumor stroma
mainly consists of the basement membrane, fibroblasts, extracellular
matrix, immune cells, and vasculature. Although most host cells in the
stroma possess certain tumor-suppressing abilities, the stroma will
change during malignancy and eventually promote growth, invasion,
and metastasis. … During recent years, the crosstalk between the
cancer cells and the tumor stroma, highly responsible for the
progression of tumors and their metastasis, has been increasingly
unveiled. …
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[17]
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[17]
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Tumor Stromal Changes [2]
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SUMMARY POINTS
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• Original in-vivo study showing increase in cancer
with HBOT (head-neck in mouse) 2.4 ATA @ 90 min,
7 days/week X +/- 30 dives. [11] – This and a few
other studies have caused the “HBOT promotes
cancer concerns” widely reported.
• Numerous papers noted above and excellent reviews
of the topic in 2012 and 2016 [1, 3] show that these
concerns are unfounded.
• Tumor response to HBOT (and tumor biology) are
not analogous to normal or non-cancerous injured
tissue biology or pathology.
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• Globally speaking lower O2 in the tumor
environment ENHANCES tumor growth and
metastasis as an adaptive mechanism. [1]
• HBOT decreases tumor cell survival, metastasis,
angiogenesis and other key promoting factors.
[1, 2, 12, 13, 14]
• HBOT has been shown to be associated with
increased survival in humans with cancer. [3]
• HBOT alters gene expression to switch to a
lesser tumorigenic metabolism [1]
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• Conventional and experimental oncology therapies shown
to have potential synergy with HBOT include (but are not
limited to):
• General Chemotherapy Uptake Improvement [1,3]
• 5-FU [1,3]
• Platinums [1]
• Taxanes [1]
• Radiation [1,3]
• Artemisinin / Artesunate [1]
• TMZ (Temozolomide ) [3]
• Ascorbic Acid [18,19,20]
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Important Therapy-Synergy Note:
• With oxidative therapies always start with lower
pressures (1.3 to 1.5 ATA) and do a test dive at 45
minutes bottom time.
• This is especially critical if HBOT and the oxidant
therapy are administered on the same day.
• For other synergy “lessons learned” see my next
presentation.
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Thank you!
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